Strata Critical Medical, Inc. (SRTA) Earnings History
Profitable7 years of earnings data (2019–2025) · Positive TTM net income
Loading earnings history...
Strata Critical Medical, Inc. (SRTA) Earnings Overview
As of June 28, 2026, Strata Critical Medical, Inc. (SRTA) reported trailing twelve-month net income of $47M, reflecting +242.9% year-over-year growth. The company earned $0.52 per diluted share over the past four quarters, with a net profit margin of 21.0%.
Looking at the long-term picture, SRTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $41M in fiscal 2025, representing a new all-time high.
Strata Critical Medical, Inc. maintains industry-leading profitability with a gross margin of 20.9%, operating margin of -11.3%, and net margin of 21.0%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ENSG ($363M net income, 6.8% margin), ADUS ($100M net income, 6.7% margin), CCRN (-$99M net income, -9.0% margin), SRTA has outperformed on profitability metrics. Compare SRTA vs ENSG →
SRTA Earnings vs Peers
Earnings metrics vs comparable public companies
SRTA Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $41M | +251.4% | -$22M | $0.50 | 21.0% | -11.3% |
| 2024 | -$27M | +51.3% | -$34M | $-0.35 | -11.0% | -13.6% |
| 2023 | -$56M | -105.7% | -$68M | $-0.76 | -24.9% | -30.3% |
| 2022 | -$27M | +31.9% | -$54M | $-0.38 | -18.7% | -36.6% |
| 2021 | -$40M | -294.2% | -$24M | $-0.57 | -79.3% | -47.7% |
| 2020 | -$10M | +6.3% | -$10M | $-0.81 | -43.4% | -44.2% |
| 2019 | -$11M | - | -$12M | $-1.47 | -34.7% | -37.0% |
Download Data
Export SRTA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
7+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SRTA — Frequently Asked Questions
Quick answers to the most common questions about buying SRTA stock.
What is SRTA earnings per share (EPS)?
SRTA trailing twelve-month (TTM) diluted EPS is $0.52, reflecting +242.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2019 to 2025 is available in the table on this page.
What is Strata Critical Medical, Inc.'s net income?
Strata Critical Medical, Inc. (SRTA) trailing twelve-month net income is $47M as of 2025. Earnings grew +242.9% year-over-year.
Is SRTA profitable?
Yes, SRTA is profitable with a TTM net income of $47M and a net profit margin of +21.0%.
What is SRTA's earnings growth rate?
SRTA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2019 to 2025.
What are SRTA's profit margins?
Strata Critical Medical, Inc. net profit margin is +21.0%, operating margin is -11.3%, and gross margin is +20.9%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +16.5%.
Is SRTA growing earnings?
Yes, SRTA earnings are accelerating — EPS growth of +242.9% exceeds the 5-year CAGR of N/A. TTM net income reached $47M. Earnings momentum is strengthening.
What was SRTA's best earnings year?
Strata Critical Medical, Inc.'s highest annual net income on record is $41M, achieved in fiscal year 2025. Earnings history on this page spans 2019 to 2025 and includes all annual and quarterly figures.
What were SRTA's earnings last quarter?
SRTA's most recent reported quarter was Q1 2026. Net income was $2M with diluted EPS of $0.03. For a full breakdown of all quarters, see the quarterly earnings table on this page.